BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Glypican-3
1
Bi-specific T1 positive-contrast-enhanced magnetic resonance imaging molecular probe for hepatocellular carcinoma in an orthotopic mouse model
4/15/2022 9:40:09 AM | Browse: 355 | Download: 1321
2
Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
8/25/2020 9:45:46 AM | Browse: 607 | Download: 1027
3
Novel molecular targets in hepatocellular carcinoma
8/21/2020 1:38:19 AM | Browse: 655 | Download: 870
4
Development and in vitro study of bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma
6/28/2019 12:22:27 PM | Browse: 855 | Download: 1325
5
Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma
3/31/2019 7:22:50 AM | Browse: 838 | Download: 1144
6
Positron emission tomography combined with computed tomography finding: Low glucose metabolism in hepatocellular carcinoma with GPC3 expression
1/26/2018 2:31:05 AM | Browse: 846 | Download: 1287
7
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
12/31/2015 1:27:00 PM | Browse: 1133 | Download: 1802
8
Biomarkers for the early diagnosis of hepatocellular carcinoma
9/28/2015 6:06:00 PM | Browse: 1177 | Download: 1544
9
Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis
8/26/2014 5:16:00 PM | Browse: 891 | Download: 701
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345